Insmed (INSM) Other Non-Current Liabilities (2011 - 2026)

Insmed's (INSM) quarterly Other Non-Current Liabilities came in at $5.7 million in Q1 2026, down 96.96% year-on-year from $187.2 million in Q1 2025, and up 0.67% quarter-over-quarter from $5.6 million in Q4 2025.

Insmed (INSM) Other Non-Current Liabilities (2011 - 2026) Analysis & Trends

Insmed's Other Non-Current Liabilities history runs 16 years deep, the most recent figure standing at $5.7 million for Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 96.96% year-over-year to $5.7 million in Q1 2026; TTM through Mar 2026 was $5.7 million, a 96.96% decrease from a year earlier, with the FY2025 full-year figure at $5.6 million, down 96.66% from the prior year.
  • Other Non-Current Liabilities improved to $5.7 million in Q1 2026 per INSM's latest filing, from $5.6 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $187.2 million in Q1 2025 and bottomed at $5.6 million in Q3 2025.
  • The 5-year median for Other Non-Current Liabilities is $62.1 million (2022), against an average of $72.1 million.
  • Across the five-year window, Other Non-Current Liabilities soared 2075.64% in 2024 and sank 96.96% in 2026, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $58.1 million in 2022, then soared by 45.61% to $84.6 million in 2023, then soared by 99.65% to $168.9 million in 2024, then slumped by 96.66% to $5.6 million in 2025, then climbed by 0.67% to $5.7 million in 2026.
  • Per Business Quant, the three latest INSM Other Non-Current Liabilities figures stand at $5.7 million (Q1 2026), $5.6 million (Q4 2025), and $5.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Insmed 23.26 Bn 22.03 Bn 258.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 5.68 Mn
Dec 31, 2025 5.65 Mn
Sep 30, 2025 5.60 Mn
Jun 30, 2025 180.50 Mn
Mar 31, 2025 187.20 Mn
Dec 31, 2024 168.90 Mn
Jun 30, 2024 169.70 Mn
Mar 31, 2024 73.40 Mn
Dec 31, 2023 84.60 Mn
Sep 30, 2023 69.90 Mn
Jun 30, 2023 7.80 Mn
Mar 31, 2023 6.20 Mn
Dec 31, 2022 58.10 Mn
Sep 30, 2022 8.00 Mn
Jun 30, 2022 55.60 Mn
Mar 31, 2022 66.12 Mn
Dec 31, 2021 75.67 Mn
Sep 30, 2021 23.88 Mn
Jun 30, 2021 12.81 Mn
Mar 31, 2021 9.30 Mn